help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2004-2071
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
90/5/3001    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leaños-Miranda, A.
Right arrow Articles by Conn, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leaños-Miranda, A.
Right arrow Articles by Conn, P. M.
Related Collections
Right arrow Neuroendocrinology and Pituitary
Right arrow Female Endocrinology
Right arrow Male Endocrinology
The Journal of Clinical Endocrinology & Metabolism Vol. 90, No. 5 3001-3008
Copyright © 2005 by The Endocrine Society

In Vitro Coexpression and Pharmacological Rescue of Mutant Gonadotropin-Releasing Hormone Receptors Causing Hypogonadotropic Hypogonadism in Humans Expressing Compound Heterozygous Alleles

Alfredo Leaños-Miranda, Alfredo Ulloa-Aguirre, Jo Ann Janovick and P. Michael Conn

Research Unit in Reproductive Medicine (A.L.-M., A.U.-A., P.M.C.), Instituto Mexicano del Seguro Social, México D.F. 10101, Mexico; Divisions of Neuroscience and Reproductive Biology (A.L.-M., J.A.J., P.M.C., A.U.-A.), Oregon National Primate Research Center, Beaverton, Oregon 97006; and Department of Physiology and Pharmacology and Cell and Developmental Biology, Oregon Health and Science University (P.M.C.), Portland, Oregon 97239

Address all correspondence and requests for reprints to: P. Michael Conn, Oregon National Primate Research Center/Oregon Health and Science University, 5050 NW 185th Avenue, Beaverton, Oregon 97006. E-mail: connm{at}ohsu.edu; or Alfredo Leaños-Miranda, Research Unit in Reproductive Medicine, Instituto Mexicano del Seguro Social, Apdo. Postal 99–065, Unidad Independencia, México D.F., C.P. 10101, México. E-mail: alfredo{at}intranet.com.mx.

We analyzed the function of mutant GnRH receptor (GnRHR) pairs associated with compound heterozygous patients showing complete or partial forms of hypogonadotropic hypogonadism. We did this to examine potential interactions between misfolded mutants that may influence net receptor function and response to pharmacological rescue. Nine pairs of GnRHR mutants and an unreported combination (L314X(stop)/R262Q) were studied. Coexpression of each pair of mutants in COS-7 cells resulted in an active predominant effect (Q106R/L266R, A171T/Q106R, T32I/C200Y, and R262Q/A129D mutant GnRHR pairs), an additive effect (R262Q/Q106R, N10K/Q106R, and R262Q/Y284C human GnRHR pairs), or a dominant-negative effect (L314X(stop)/Q106R, Q106R+S217R/R262Q, and L314X(stop)/R262Q GnRHRs). For all combinations, addition of the pharmacoperone IN3 increased both agonist binding and effector coupling. The IN3 response was unpredictable because responses could be either similar, higher, or lower, compared with that exhibited by the less affected mutant. The clinical phenotype in patients expressing complex heterozygous alleles appears to be dictated by both the contribution from each mutant and a dominant-negative effect similar to that reported for mutants and wild-type receptor. Depending on the genotype, partial or full restoration of receptor function in response to pharmacological chaperones may be achievable goals in patients bearing inactivating mutations in the GnRHR gene.




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
K. M. Wannemacher, P. N. Yadav, and R. D. Howells
A Select Set of Opioid Ligands Induce Up-Regulation by Promoting the Maturation and Stability of the Rat {kappa}-Opioid Receptor in Human Embryonic Kidney 293 Cells
J. Pharmacol. Exp. Ther., November 1, 2007; 323(2): 614 - 625.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
P. M. Conn, A. Ulloa-Aguirre, J. Ito, and J. A. Janovick
G Protein-Coupled Receptor Trafficking in Health and Disease: Lessons Learned to Prepare for Therapeutic Mutant Rescue in Vivo
Pharmacol. Rev., September 1, 2007; 59(3): 225 - 250.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
P M. Conn, J. A. Janovick, S. P Brothers, and P. E Knollman
'Effective inefficiency': cellular control of protein trafficking as a mechanism of post-translational regulation.
J. Endocrinol., July 1, 2006; 190(1): 13 - 16.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society